Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Covington
Moodys
Julphar
Accenture
Deloitte

Generated: April 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for CC-223

« Back to Dashboard

US Patents for CC-223

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
CC-223 ➤ Try a Free Trial Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Try a Free Trial
CC-223 ➤ Try a Free Trial Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Try a Free Trial
CC-223 ➤ Try a Free Trial Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Try a Free Trial
CC-223 ➤ Try a Free Trial Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Try a Free Trial
CC-223 ➤ Try a Free Trial Methods of synthesis and purification of heteroaryl compounds Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Try a Free Trial
CC-223 ➤ Try a Free Trial Methods of synthesis and purification of heteroaryl compounds Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Try a Free Trial
CC-223 ➤ Try a Free Trial Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for CC-223

Drugname Country Document Number Estimated Expiration Related US Patent
CC-223 European Patent Office 3131552 2034-04-16 ➤ Try a Free Trial
CC-223 Japan 2017514806 2034-04-16 ➤ Try a Free Trial
CC-223 New Zealand 629860 2034-04-16 ➤ Try a Free Trial
CC-223 World Intellectual Property Organization (WIPO) 2015160868 2034-04-16 ➤ Try a Free Trial
CC-223 Argentina 073995 2028-10-27 ➤ Try a Free Trial
CC-223 Australia 2009320137 2028-10-27 ➤ Try a Free Trial
CC-223 Canada 2740975 2028-10-27 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Merck
AstraZeneca
Medtronic
Fuji
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.